Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 3

eBook: US $149 Special Offer (PDF + Printed Copy): US $253
Printed Copy: US $179
Library License: US $596
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-069-7 (Print)
ISBN: 978-1-68108-068-0 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810806801150301


Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimers Disease research.

The third volume of this series features research on

  • - perfusional modifications in prodromal Alzheimer's disease,
  • - BACE inhibition treatment,
  • - frontotemporal dementia caused by progranulin mutations
  • - evidence-based treatment for psychological symptoms of Alzheimer’s Disease


- Pp. i-ii (2)
Download Free

List of Contributors

- Pp. iii-iv (2)
Download Free

Alpha and Theta Rhythms Activity is Associated to Morpho- Structural and Perfusional Modifications in Subjects with Prodromal Alzheimer`s Disease

- Pp. 3-19 (17)
Vito Davide Moretti, Prestia A, Binetti G, Zanetti O, Frisoni G B
View Abstract

New Aspects of Therapeutic Management in Alzheimer`s Disease

- Pp. 20-114 (95)
Cristian Dinu Popescu, Dan Trofin, Daniela Trofin, Bogdan Ignat, Daniela Matei
View Abstract

Evidence-Based Treatment and Prevention of Behavioural and Psychological Symptoms of Alzheimer`s Disease

- Pp. 115-134 (20)
Anne Corbett, Clive Ballard
View Abstract

BACE Inhibition as a Therapeutic Strategy for Alzheimer`s Disease

- Pp. 135-230 (96)
Genevieve Evin, Stephanie J. Fuller, Jenny M. Gunnersen
View Abstract

The Development of Drug Therapies for Frontotemporal Dementia Caused by <i>Progranulin</i> Mutations

- Pp. 231-291 (61)
Louis De Muynck, Philip Van Damme
View Abstract

Subject Index

- Pp. 292-297 (6)
Download Free


.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Advances in Alzheimer Research.